Oral zinc and the second eye in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 7, 1996, Pages 1225-1235

  Stur, Michael ^a,b   Tittl, Michael ^a   Reitner, Andreas ^a   Meisinger, Vanee ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

age related macular degeneration; choroidal neovascularization; fluorescein angiography; visual acuity; zinc sulfate

Indexed keywords

ZINC;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT FAILURE; TREATMENT OUTCOME; ZINC METABOLISM;

ADMINISTRATION, ORAL; AGED; CHOROID; COLOR PERCEPTION; CONTRAST SENSITIVITY; COPPER; DOUBLE-BLIND METHOD; ERYTHROCYTE COUNT; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; NEOVASCULARIZATION, PATHOLOGIC; RETINAL DETACHMENT; RISK FACTORS; SULFATES; VISUAL ACUITY; ZINC COMPOUNDS; ZINC SULFATE;

EID: 0029931478     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ferris FD. Senile macular degeneration: Review of epidemiologic features. Am J Epidemiol. 1983;118:132-151.
2. Ferris FD, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-1642.
3. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106:192-198.
4. Risk factors for neovascular age-related macular degeneration: The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1992;110:1701-8.
5. West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol. 1994;112:222-227.
6. Baun O, Vinding T, Krogh E. Natural course in fellow eyes of patients with unilateral age-related exudative maculopathy: A fluorescein angiographic 4-year follow-up of 45 patients. Acta Ophthalmol. 1993;71:398-401.
7. Roy M, Kaiser KM. Second eye involvement in age-related macular degeneration: A four-year prospective study. Eye. 1990;4:813-818.
8. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function: Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1991;32:8-20.
9. Alexander MF, Maguire MG, Lietman TM, Snyder JR, Elman MJ, Fine SL. Assessment of visual function in patients with age-related macular degeneration and low visual acuity. Arch Ophthalmol. 1988;106:1543-1547.
10. Smith VC, Pokorny J, Diddie KR. Color matching and the Stiles-Crawford effect in observers with early age-related macular changes. J Opt Soc Am A. 1988;5:2113-2121.
11. Alvarez SL, King SP, Bhargava SK. Spectral thresholds in macular degeneration. Br J Ophthalmol. 1983;67: 508-511.
12. Wen F, Wu DZ, Wu L, Yi Y, Feng G, Zheng J. The natural history of dry type of age-related macular degeneration. Yen Ko Hsueh Pao. 1993;9:31-33.
13. Eisner A, Klein ML, Zilis JD, Watkins MD. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1992;33:3091-3102.
14. Bernth PP, Naeser K. Clinical evaluation of the Lotmar Visometer for macula testing in cataract patients. Acta Ophthalmol (Copenh). 1982;60:525-532.
15. Verriest G. Further studies on acquired deficiency of color discrimination. J Opt Soc Am. 1963;53:185-195.
16. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128-1134.
17. Bressler NM, Bressler SB, Seddon JM, Gragoudas ES, Jacobson LP. Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina. 1988;8:109-114.
18. Wyszynski RE, Bruner WE, Cano DB, Morgan KM, Davis CB, Sternberg P. A donor-age-dependent change in the activity of alpha-mannosidase in human cultured RPE cells. Invest Ophthalmol Vis Sci. 1989;30:2341-2347.
19. Ulshafer RJ. Zinc content in melanosomes of degenerating RPE as measured by X-ray mapping. Prog Clin Biol Res. 1989;314:131-139.
20. Tate D Jr, Newsome DA, Oliver PD. Metallothionein shows an age-related decrease in human macular retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1993;34:2348-2351.
21. van der Schaft TL, de Bruijn WC, Mooy CM, Ketelaars DA, de Jong PT. Element analysis of the early stages of age-related macular degeneration. Arch Ophthalmol. 1992;110:389-394.
22. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration: Prognosis and risk factors. Ophthalmology. 1994;101: 1522-1528.
23. Bressler SB, Maguire MG, Bressler NM, Fine SL. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration: The Macular Photocoagulation Study Group. Arch Ophthalmol. 1990;108:1442-1447.
24. Schatz H, McDonald HR. Atrophic macular degeneration: Rate of spread of geographic atrophy and visual loss. Ophthalmology. 1989;96:1541-1551.
25. Antioxidant status and neovascular age-related macular degeneration: Eye Disease Case-Control Study Group. Arch Ophthalmol. 1993;111:104-109.
26. Kaminski MS, Yolton DP, Jordan WT, Yolton RL. Evaluation of dietary antioxidant levels and supplementation with ICAPS-Plus and Ocuvite. J Am Optom Assoc. 1993;64:862-870.
27. Tsang NC, Penfold PL, Snitch PJ, Billson F. Serum levels of antioxidants and age-related macular degeneration. Doc Ophthalmol. 1992;81:387-400.
28. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128:700-710.
29. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration: Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-1420.
30. Christen WG Jr. Antioxidants and eye disease. Am J Med. 1994;97:14S-17S.